Skip to content

treatment of angiokeratoma of scrotum

To compare the efficacy and safety of sclerotherapy using 1% sodium tetradecyl sulphate, 0.25% sodium tetradecyl sulphate and radiofrequency ablation in treatment of angiokeratoma of Fordyce

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/022189
Enrollment
150
Registered
2019-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D239- Other benign neoplasm of skin, unspecified

Interventions

Intervention1: 1% sodium tetradecyl sulphate: Sodium tetradecyl sulphate (STS) is a sclerosing agent, that obliterate the blood vessels. It has been successfully used to treat varicose veins, gastroes

Sponsors

Pt B D Sharma PGIMS Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of more than 18 years of age with angiokeratoma of Fordyce on scrotum will be taken up for the study

Exclusion criteria

Exclusion criteria: (1) Deep venous thrombosis, (2) Saphenofemoral junction/saphenopopliteal junction incompetence, (3) Myocardial decompensation, (4) History of bleeding disorders or Hypercoagulable state, (5) Dependency edema, (6) Diabetes mellitus (7) Varicocele (8) Any overlying dermatological manifestations such as eczema, psoriasis (9) Any type of infections

Design outcomes

Primary

MeasureTime frame
Grading of number of lesions- number of lesions will be monitored for whether there is partial regression or complete regression at every sitting at weekly intervalTimepoint: Grading of number of lesions- number of lesions will be monitored for whether there is partial regression or complete regression at every sitting at weekly interval

Secondary

MeasureTime frame
10 point pain scaleTimepoint: At the end of the study;Visual Analogue scale 1. 7-10 - Excellent response 2. 4-6 - Good response 3. 0-3 - Poor response Timepoint: At the end of the study;Physicianâ??s Global Assessment- 1.Excellent - 70% reduction in total number of lesions 2.Good - 51-70% reduction in total number of lesions 3.Fair - 30-50% reduction in total number of lesions 4.Poor - 30% reduction in total number of lesionsTimepoint: At the starting of the study and at the end of the study we will calculate the reduction in the number of lesions

Countries

India

Contacts

Public ContactPriyadarshini Sahu

Pt. B. D. Sharma, PGIMS, Rohtak

priyadarshini.sahu.9@gmail.com9416536159

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026